Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Use corticosteroid cream and triamcinolone injections for treating alopecia areata, and consider wigs and tranquilizers for support.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Some women with common hair loss may develop permanent hair loss.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PRP more effective than minoxidil 5% for treating alopecia areata.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.